Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in elderly patients with intertrochanteric fracture
TCTR20220620001Phase 4Unknown
- Sponsor
- Mahidol University
- Start
- Sep 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in intertrochanteric fracture, sponsored by Mahidol University. Status: unknown.
02
Drugs
denosumab
03
Conditions
intertrochanteric fracture
Beyond the preview
Go deeper on TCTR20220620001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220620001.